HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Joseph D'Souza Selected Research

oxcarbazepine (Trileptal)

11/2006Efficacy, safety, and tolerability of oxcarbazepine monotherapy.
11/2006Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy.
7/2006A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.
11/2005Long-term safety and tolerability of oxcarbazepine in children: a review of clinical experience.
10/2005A cost comparison of alternative regimens for treatment-refractory partial seizure disorder: an econometric analysis.
11/2004Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy.
9/2003Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy.
4/2003Safety and tolerability of oxcarbazepine in elderly patients with epilepsy.
5/2002Effects of oxcarbazepine on sodium concentration and water handling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Joseph D'Souza Research Topics

Disease

7Epilepsy (Aura)
11/2015 - 05/2002
7Seizures (Seizure)
06/2012 - 05/2002
4Partial Epilepsies (Epilepsy, Partial)
05/2013 - 09/2003
4Dizziness (Lightheadedness)
01/2009 - 04/2003
4Nausea
01/2009 - 04/2003
3Vomiting
01/2009 - 04/2003
2Fatigue
07/2006 - 11/2005
2Exanthema (Rash)
07/2006 - 11/2005
2Hyponatremia
04/2003 - 05/2002
1Generalized Epilepsy
06/2012
1Absence Epilepsy (Absence Seizure)
06/2012
1Bipolar Disorder (Mania)
07/2006
1Diplopia (Double Vision)
07/2006
1Headache (Headaches)
11/2005

Drug/Important Bio-Agent (IBA)

9oxcarbazepine (Trileptal)FDA LinkGeneric
11/2006 - 05/2002
2etiracetam (levetiracetam)FDA LinkGeneric
11/2015 - 06/2012
2lacosamideFDA Link
05/2013 - 01/2009
2Anticonvulsants (Antiepileptic Drugs)IBA
10/2005 - 04/2003
2SodiumIBA
04/2003 - 05/2002
12- (2- oxo- 4- propylpyrrolidin- 1- yl)butanamide (brivaracetam)IBA
11/2015
1Ethosuximide (Zarontin)FDA LinkGeneric
06/2012
1lamotrigine (Lamictal)FDA LinkGeneric
06/2012
1Valproic Acid (Valproate, Semisodium)FDA LinkGeneric
06/2012
1topiramate (Topamax)FDA LinkGeneric
06/2012
1Immunoglobulin E (IgE)IBA
06/2012
1Cytidine Diphosphate (CDP)IBA
11/2005
1Carbamazepine (Tegretol)FDA LinkGeneric
05/2002
1HormonesIBA
05/2002